Marcus A. Worns

Dortmund, NW 44137, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Validation of the CLIF-C OF Score and CLIF-C ACLF Score to Predict Transplant-Free Survival in Patients with Liver Cirrhosis and Concomitant Need for Intensive Care Unit Treatment.

Validation of the CLIF-C OF Score and CLIF-C ACLF Score to Predict Transplant-Free Survival in Patients with Liver Cirrhosis and Concomitant Need for Intensive Care Unit Treatment.

Journal: Medicina (Kaunas, Lithuania)

Published: March 14, 2023

Suppressed serological vitamin A in patients with liver cirrhosis is associated with impaired liver function and clinical detoriation.

Suppressed serological vitamin A in patients with liver cirrhosis is associated with impaired liver function and clinical detoriation.

Journal: European journal of gastroenterology & hepatology

Published: July 27, 2022

Management of Hepatic Sarcoidosis.

Management of Hepatic Sarcoidosis.

Journal: Journal of gastrointestinal and liver diseases : JGLD

Published: November 29, 2021

Hepatocyte Bcl-3 protects from death-receptor mediated apoptosis and subsequent acute liver failure.

Hepatocyte Bcl-3 protects from death-receptor mediated apoptosis and subsequent acute liver failure.

Journal: Cell death & disease

Published: November 05, 2021

Sonographic assessment of low muscle quantity identifies mortality risk during COVID-19: a prospective single-centre study.

Sonographic assessment of low muscle quantity identifies mortality risk during COVID-19: a prospective single-centre study.

Journal: Journal of cachexia, sarcopenia and muscle

Published: May 13, 2021

Acquired Resistance to Antiangiogenic Therapies in Hepatocellular Carcinoma Is Mediated by Yes-Associated Protein 1 Activation and Transient Expansion of Stem-Like Cancer Cells.

Acquired Resistance to Antiangiogenic Therapies in Hepatocellular Carcinoma Is Mediated by Yes-Associated Protein 1 Activation and Transient Expansion of Stem-Like Cancer Cells.

Journal: Hepatology communications

Published: April 29, 2021

High pre-treatment static and dynamic alpha-fetoprotein values predict reduced overall survival in hepatocellular carcinoma.

High pre-treatment static and dynamic alpha-fetoprotein values predict reduced overall survival in hepatocellular carcinoma.

Journal: United European gastroenterology journal

Published: November 23, 2020

High pretreatment static and dynamic alpha-fetoprotein values predict reduced overall survival in hepatocellular carcinoma.

High pretreatment static and dynamic alpha-fetoprotein values predict reduced overall survival in hepatocellular carcinoma.

Journal: United European gastroenterology journal

Published: August 31, 2020

Urinary ethyl glucuronide (uEtG) as a marker for alcohol consumption in liver transplant candidates: a real-world cohort.

Urinary ethyl glucuronide (uEtG) as a marker for alcohol consumption in liver transplant candidates: a real-world cohort.

Journal: Zeitschrift fur Gastroenterologie

Published: January 14, 2020

Impact of acute-on-chronic liver failure and decompensated liver cirrhosis on psychosocial burden and quality of life of patients and their close relatives.

Impact of acute-on-chronic liver failure and decompensated liver cirrhosis on psychosocial burden and quality of life of patients and their close relatives.

Journal: Health and quality of life outcomes

Published: September 06, 2019

Application of patient-derived liver cancer cells for phenotypic characterization and therapeutic target identification.

Application of patient-derived liver cancer cells for phenotypic characterization and therapeutic target identification.

Journal: International journal of cancer

Published: July 11, 2018

Safety and efficacy of afatinib as add-on to standard therapy of gemcitabine/cisplatin in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, phase I trial with an extensive biomarker program.

Safety and efficacy of afatinib as add-on to standard therapy of gemcitabine/cisplatin in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, phase I trial with an extensive biomarker program.

Journal: BMC cancer

Published: May 05, 2018

Showing 1-12 of 47

Last Updated: 09/26/2026